|
23 Mar 2020 |
Bayer and Curadev sign research collaboration and license agreement to develop novel STING antagonists across indications
|
|
18 Mar 2020 |
Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies
|
|
18 Mar 2020 |
RIBOMIC Enters License Agreement with AJU Pharma for RBM-007 in Age-related Macular Degeneration
|
|
18 Mar 2020 |
HORAMA Signs Exclusive License Agreement with Leiden University Medical Center Targeting CRB1 Gene Mutations to Treat Inherited Retinal Dystrophies
|
|
17 Mar 2020 |
Eureka Therapeutics Completes $45 Million Series E Financing and Enters into Strategic Collaboration with Lyell Immunopharma
|
|
16 Mar 2020 |
Tetraphase Pharmaceuticals and AcelRx Pharmaceuticals Enter into Definitive Merger Agreement
|
|
16 Mar 2020 |
BioNTech and Fosun Pharma form COVID-19 vaccine strategic alliance in China
|
|
15 Mar 2020 |
Nurix Therapeutics Closes $120 Million Financing to Advance Targeted Protein Modulation Drug Pipeline
|
|
11 Mar 2020 |
Vir Biotechnology Announces Research Collaboration with the National Institutes of Health Vaccine Research Center on Antibodies Against Coronaviruses
|
|
10 Mar 2020 |
Bridge Biotherapeutics Enters AI-based Research Collaboration with Atomwise to Expand Pellino Inhibitor Pipeline
|
|
09 Mar 2020 |
MolMed signs a multi-year agreement and announces the beginning of a new collaboration in the field of T cell therapies
|
|
09 Mar 2020 |
Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets
|
|
09 Mar 2020 |
Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement
|
|
06 Mar 2020 |
Orionis Biosciences Debuts with Major Pharmaceutical Collaboration to Tackle Industry’s Most Challenging Protein Targets
|
|
04 Mar 2020 |
Voluntis and Bristol-Myers Squibb to Co-Develop Digital Therapeutics for Oncology
|
|
04 Mar 2020 |
Vir and Alnylam Expand Collaboration to Advance RNAi Therapeutics for the Treatment of Coronavirus Infection, Including COVID-19
|
|
04 Mar 2020 |
Iktos and SRI International Announce Collaboration to Combine Artificial Intelligence and Novel Automated Discovery Platform for Accelerated Development of New Anti-Viral Therapies
|
|
02 Mar 2020 |
Gilead to Acquire Forty Seven for $4.9 Billion
|
|
29 Feb 2020 |
Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform
|
|
29 Feb 2020 |
Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies for Alzheimer’s, Parkinson’s, Neuromuscular, and Other Neurological Diseases
|
|
26 Feb 2020 |
Arcus Biosciences and Taiho Pharmaceutical Co., Ltd. Jointly Announce Taiho’s Exercise of Its Option for an Exclusive License to Zimberelimab (AB122) for Its Territories in Japan and Other Asian Countries
|
|
26 Feb 2020 |
Takeda Acquires PvP Biologics Following Results of a Phase 1 Study of TAK-062 (Kuma062) for the Treatment of Celiac Disease
|
|
25 Feb 2020 |
Peptilogics Announces CARB-X Funding to Accelerate Development of First-in-Class Antibiotics to Address the Global Threat of Multi-drug Resistant Bacteria
|
|
25 Feb 2020 |
Bicycle Therapeutics Announces Exclusive Strategic Collaboration with Genentech to Develop and Commercialize Bicycle®-based Immuno-oncology Therapies
|
|
24 Feb 2020 |
Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*)
|
